Witnessing the stock’s movement on the chart, on April 22, 2022, Adaptive Biotechnologies Corporation (NASDAQ: ADPT) had a quiet start as it plunged -1.82% to $9.18. During the day, the stock rose to $9.69 and sunk to $9.08 before settling in for the price of $9.35 at the close. Taking a more long-term approach, ADPT posted a 52-week range of $9.20-$44.97.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -32.50%. This publicly-traded company’s shares outstanding now amounts to $141.24 million, simultaneously with a float of $138.48 million. The organization now has a market capitalization sitting at $1.42 billion. At the time of writing, stock’s 50-day Moving Average stood at $12.83, while the 200-day Moving Average is $26.17.
If we measure the efficiency of the company that is accounted for 858 employees. For the Profitability, stocks gross margin was +59.02, operating margin was -135.39 and Pretax Margin of -134.31.
Adaptive Biotechnologies Corporation (ADPT) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Adaptive Biotechnologies Corporation’s current insider ownership accounts for 2.20%, in contrast to 87.50% institutional ownership. According to the most recent insider trade that took place on Apr 07, this organization’s Chief Operating Officer sold 831 shares at the rate of 13.17, making the entire transaction reach 10,944 in total value, affecting insider ownership by 122,893. Preceding that transaction, on Mar 09, Company’s CEO and Chairman sold 14,815 for 12.46, making the whole transaction’s value amount to 184,595. This particular insider is now the holder of 1,916,154 in total.
Adaptive Biotechnologies Corporation (ADPT) Earnings and Revenue Records
As on 9/29/2021, Multinational firm has announced its last quarter scores, in which it reported -$0.4 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.42) by $0.02. This company achieved a net margin of -134.30 while generating a return on equity of -30.77. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
Adaptive Biotechnologies Corporation’s EPS decrease for this current 12-month fiscal period is -32.50% and is forecasted to reach -1.62 in the upcoming year.
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Trading Performance Indicators
Let’s observe the current performance indicators for Adaptive Biotechnologies Corporation (ADPT). It’s Quick Ratio in the last reported quarter now stands at 3.40. The Stock has managed to achieve an average true range (ATR) of 0.92. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.18.
In the same vein, ADPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.48, a figure that is expected to reach -0.45 in the next quarter, and analysts are predicting that it will be -1.62 at the market close of one year from today.
Technical Analysis of Adaptive Biotechnologies Corporation (ADPT)
Going through the that latest performance of [Adaptive Biotechnologies Corporation, ADPT]. Its last 5-days volume of 1.28 million indicated improvement to the volume of 1.25 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 4.85% While, its Average True Range was 0.91.
Raw Stochastic average of Adaptive Biotechnologies Corporation (ADPT) in the period of the previous 100 days is set at 0.47%, which indicates a major fall in contrast to 1.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 44.27% that was lower than 81.45% volatility it exhibited in the past 100-days period.